logo

JBIO

Jade Biosciences·NASDAQ
--
--(--)
--
--(--)

JBIO fundamentals

Jade Biosciences (JBIO) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.86 (YoY +97.14%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.86
+97.14%
Report date
Aug 13, 2025
EPS
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-833-9.1-11.9-15.75-17.15-19.6-21.35-23.45-26.6-24.85-25.9-29.05-30.1-19.6-6.65-12.1-0.86
Forecast
-5.4833-9.1-10.9979-9.7414-15.575-17.4423-21.0928-20.9979-24.36-24.2445-23.7609-26.7598-28.7826-16.3613-6.573-6.025-0.4333
Surprise
-15091.58%
0.00%
-8.20%
-61.68%
-10.11%
-12.37%
-1.22%
-11.68%
-9.20%
-2.50%
-9.00%
-8.56%
-4.58%
-19.79%
-1.17%
-100.83%
-98.48%
Revenue
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
00000000000000000
Forecast
00000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call